CanadaBis Capital Inc. (TSXV: CANB)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
CanadaBis Capital Inc. (TSXV: CANB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.53M.
trading between 0.01 and 0.10.
Tweenvest scores CanadaBis Capital Inc. across four factors: quality 52/100, value 46/100, growth 100/100. Its strongest factor is growth.
CANB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.53M
- Revenue (TTM)
- $10.76M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- CA$0.10
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 141.02M
- Employees
- —
- Next earnings
- —
About CanadaBis Capital Inc.
CanadaBis Capital Inc. is a Canadian firm specializing in the production and distribution of recreational cannabis and its extracted forms. The organization's business activities are divided into three principal divisions: Cultivation and Wholesale, Retail, and Extraction and Tolling. Its Cultivation and Wholesale segment is dedicated to growing and supplying cannabis and related goods, channeling them through provincial liquor and cannabis regulatory boards. The Retail division focuses on direct-to-consumer sales of cannabis and complementary products from locations owned and managed by the company. Furthermore, the Extraction and Tolling segment provides specialized cannabinoid extraction services to other licensed producers in the industry. The corporate headquarters for CanadaBis Capital Inc. are situated in Red Deer, Canada.
- ISIN
- CA13530Q1046
- Founded
- 2016
- Listed since
- Mar 10, 2017
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.02 | -3.54% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.56 | -0.94% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.39 | -1.96% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.39 | -0.65% |
Figures last refreshed Aug 18, 2026.